Holderness Investments Company’s Elevance Health ELV Stock Holding History

Holderness Investments Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,261	Closed	-$656K	–	260
2024 Q3	$656K	Buy	1,261 +1	+0.1%	+$534	0.14%	135
2024 Q2	$683K	Buy	1,260 +4	+0.3%	+$2.11K	0.16%	122
2024 Q1	$651K	Buy	1,256 +75	+6%	+$37.3K	0.16%	132
2023 Q4	$557K	Buy	1,181 +10	+0.9%	+$4.62K	0.15%	134
2023 Q3	$510K	Buy	1,171 +21	+2%	+$9.53K	0.2%	110
2023 Q2	$511K	Buy	1,150 +162	+16%	+$74.7K	0.19%	115
2023 Q1	$454K	Buy	988 +35	+4%	+$16.7K	0.18%	117
2022 Q4	$489K	Hold	953	–	–	0.21%	109
2022 Q3	$433K	Buy	953 +50	+6%	+$23.9K	0.2%	115
2022 Q2	$436K	Hold	903	–	–	0.18%	119
2022 Q1	$444K	Sell	903 -27	-3%	-$12.3K	0.15%	141
2021 Q4	$431K	Hold	930	–	–	0.13%	158
2021 Q3	$347K	Hold	930	–	–	0.11%	163
2021 Q2	$355K	Hold	930	–	–	0.12%	160
2021 Q1	$334K	Sell	930 -160	-15%	-$51.5K	0.12%	159
2020 Q4	$350K	Hold	1,090	–	–	0.14%	137
2020 Q3	$293K	Buy	1,090 +10	+0.9%	+$2.69K	0.12%	143
2020 Q2	$284K	Buy	+1,080	New	+$288K	0.13%	143

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Holderness Investments Company's ELV Position: Q4 2024 in Review

Holderness Investments Company sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,261 shares — an estimated $656K sold.

Holderness Investments Company first reported a position in ELV in Q2 2020 and held it in 18 quarters. The position peaked at $683K in Q2 2024. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Holderness Investments Company reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Holderness Investments Company sold 1,261 Elevance Health shares in Q4 2024, an estimated $656K.
Holderness Investments Company first reported a position in Elevance Health in Q2 2020 and held it in 18 quarters.
Holderness Investments Company's Elevance Health position peaked at $683K in Q2 2024.
1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Holderness Investments Company's 13F filing for Q4 2024, filed 11 Feb 2025.